Capricor Therapeutics, Inc. (CAPR)
34.70
+0.11
(+0.32%)
USD |
NASDAQ |
Apr 17, 16:00
34.76
+0.06
(+0.17%)
Pre-Market: 20:00
Capricor Therapeutics Free Cash Flow : -81.54M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Inovio Pharmaceuticals, Inc. | -88.92M |
| Repligen Corp. | 91.69M |
| Vaxart, Inc. | 7.569M |
| Penumbra, Inc. | 174.93M |
| Allogene Therapeutics, Inc. | -149.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -23.57M |
| Cash from Investing (Quarterly) | 43.09M |
| Cash from Financing (Quarterly) | 248.82M |
| Free Cash Flow Per Share (Quarterly) | -0.5873 |
| Free Cash Flow to Equity (Quarterly) | -28.72M |
| Free Cash Flow to Firm (Quarterly) | -25.65M |
| Free Cash Flow Yield | -5.06% |